Table of Content

1 INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study


2 RESEARCH METHODOLOGY


3 EXECUTIVE SUMMARY


4 MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rising Cradiovascular Disease Burden
4.2.2 Growing Preference for Minimally Invasive Surgeries
4.2.3 Technological Advancements in Guidewires
4.3 Market Restraints
4.3.1 High Cost of Surgical Guidewires
4.4 Porter’s Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry


5 MARKET SEGMENTATION
5.1 By Product
5.1.1 Peripheral Guidewires
5.1.2 Coronary Guidewires
5.1.3 Urology Guidewires
5.1.4 Neurovascular Guidewires
5.2 By Coating
5.2.1 Coated
5.2.2 Non Coated
5.3 By Raw Material
5.3.1 Nitinol
5.3.2 Stainless Steel
5.3.3 Others
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East and Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East and Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America


6 COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 Boston Scientific Corporation
6.1.2 Abbott Laboratories
6.1.3 Terumo Medical Corporation
6.1.4 ASAHI INTECC CO., LTD.
6.1.5 Cardinal Health
6.1.6 B. Braun Melsungen AG
6.1.7 AngioDynamics
6.1.8 Medtronic Plc
6.1.9 Stryker Corporation
6.1.10 Cook Medical Incorporated


7 MARKET OPPORTUNITIES AND FUTURE TRENDS